Oral insulin spray could offer quality of life improvement for diabetics

06/10/2005 | Medscape (free registration)

An investigational oral insulin spray appears to be effective in postprandial glucose control in the first two hours after administration and its use just a few minutes before meals could present a dramatic quality of life improvement for diabetics, according to a new study. The insulin spray, called ORA-LYN, delivered lower amounts of insulin than injected insulin in the study, but the maximum insulin concentration was significantly shorter with the oral spray than the injection and glucose consumption increased more rapidly.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC